Search
01/12/2024
Efficacy and safety of antistaphylococcal penicillin or cephazolin-based combinations versus monotherapy for methicillin-susceptible Staphylococcus aureus infective endocarditis: A propensity score analysis of nationwide prospective cohort
Calderón-Parra, J, Grillo, S, Muñoz, P, Machado-Vilchez, M, Delgado-Montero, A, De Alarcón-González, A, Poyato-Borrego, M, Goenaga-Sánchez, M, Fariñas-Alvarez, MC, Miró, JM, López-Cortés, LE, Rodríguez-García, R, Oteo, JA, Martínez-Ramos, A. Efficacy and safety of antistaphylococcal penicillin or cephazolin-based combinations versus monotherapy for methicillin-susceptible Staphylococcus aureus infective endocarditis: A propensity score analysis of nationwide prospective cohort. JOURNAL OF INFECTION. 2024; 89(6)DOI:10.1016/j.jinf.2024.106352. PMID:39561880. IF:11.900(Q1/1D).
01/12/2024
The impact of the COVID-19 pandemic on healthcare services utilization among people living with HIV in Catalonia, Spain: A population-based cohort study
Pan Y.-H., Nomah D.K., Montoro-Fernandez M., Moreno-Fornés S., Díaz Y., Aceitón J., Bruguera A., Llibre J.M., Domingo P., Imaz A., Vilaró I., Falcó V., Reyes-Urueña J., Miro J.M., Casabona J.. The impact of the COVID-19 pandemic on healthcare services utilization among people living with HIV in Catalonia, Spain: A population-based cohort study. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2024; 42(10)DOI:10.1016/j.eimc.2023.09.001. PMID:38218704. IF:2.500(Q2/5D).
01/12/2024
Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol
Salazar, J, Arranz, MJ, Martin-Broto, J, Bautista, F, Martínez-García, J, Martínez-Trufero, J, Vidal-Insua, Y, Echebarria-Barona, A, Díaz-Beveridge, R, Valverde, C, Luna, P, Vaz-Salgado, MA, Blay, P, Alvarez, R, Sebio, A. Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol. Pharmaceutics. 2024; 16(12)DOI:10.3390/pharmaceutics16121585. PMID:39771563. IF:5.500(Q1/1D).
01/12/2024
HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study
Moura, DS, Mondaza-Hernandez, JL, Sanchez-Bustos, P, Peña-Chilet, M, Cordero-Varela, JA, Lopez-Alvarez, M, Carrillo-Garcia, J, Martin-Ruiz, M, Romero-Gonzalez, P, Renshaw-Calderon, M, Ramos, R, Marcilla, D, Alvarez-Alegret, R, Agra-Pujol, C, Izquierdo, F, Ortega-Medina, L, Martin-Davila, F, Hernandez-Leon, CN, Romagosa, C, Salgado, MAV, Lavernia, J, Bagué, S, Mayodormo-Aranda, E, Alvarez, R, Valverde, C, Martinez-Trufero, J, Castilla-Ramirez, C, Gutierrez, A, Dopazo, J, Hindi, N, Garcia-Foncillas, J, Martin-Broto, J. HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study. CELLULAR AND MOLECULAR LIFE SCIENCES. 2024; 81(1)DOI:10.1007/s00018-024-05250-y. PMID:38758230. IF:6.200(Q1/2D).
01/12/2024
Transcriptional expression of SLC16A7 as a biomarker of occult lymph node metastases in patients with head and neck squamous cell carcinoma
Camacho, M, Vazquez-López, C, Valero, C, Holgado, A, Terra, X, Avilés-Jurado, FX, León, X. Transcriptional expression of SLC16A7 as a biomarker of occult lymph node metastases in patients with head and neck squamous cell carcinoma. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2024; 281(12)DOI:10.1007/s00405-024-08882-9. PMID:39215860. IF:2.200(Q1/3D).
01/12/2024
Severity and organ distribution of graft-versus-host disease with post-transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA-matched or single-allele mismatched stem cell transplantation
Redondo, S, Garcia-Cadenas, I, Esquirol, A, Portos, JM, Iranzo, E, Arguello-Tomas, M, Saavedra, S, Oñate, G, Caballero, AC, Garrido, A, López, J, Muntañola, A, Paviglianiti, A, Miqueleiz, S, Sierra, J, Briones, J, Martino, R. Severity and organ distribution of graft-versus-host disease with post-transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA-matched or single-allele mismatched stem cell transplantation. EUROPEAN JOURNAL OF HAEMATOLOGY. 2024; 113(6)DOI:10.1111/ejh.14294. PMID:39155459. IF:2.300(Q2/5D).
01/12/2024
Nemaline Myopathy Type 6 Caused by Variants in the KBTBD13 Gene
van Kleef, ESB, Bouman, K, Molenaar, JPF, Küsters, B, Groothuis, JT, Olivé, M, Malfatti, E, Kamsteeg, EJ, Van Engelen, BGM, Ottenheijm, CAC, Doorduin, J, Voermans, NC. Nemaline Myopathy Type 6 Caused by Variants in the KBTBD13 Gene. Neurology-Genetics. 2024; 10(6)DOI:10.1212/NXG.0000000000200214. PMID:39651462. IF:3.700(Q1/3D).
01/12/2024
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups
Vives, S, Quintela, D, Morgades, M, Cano-Ferri, I, Serrano, A, Acuña-Cruz, E, Cervera, M, Díaz-Beyá, M, Vidriales, B, Raposo-Puglia, JA, Arnan, M, Garrido, A, Balerdi, A, Cabello, AI, Herrera-Puente, P, Serrano, J, Coll, R, Tormo, M, López-Marín, J, García-Avila, S, Casado, MS, Padilla, I, Rodríguez-Macías, G, Calbacho, M, Puchol, A, Hernández, A, Torres, M, Costilla, L, Colorado, MM, Martínez-Cuadrón, D, Esteve, J, Montesinos, P. Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups. Cancers. 2024; 16(23)DOI:10.3390/cancers16234028. PMID:39682214. IF:4.400(Q2/3D).
01/12/2024
Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial
García-Alfonso, P, Elez, E, Soto-Alsar, J, Páez, D, Fernández-Montes, A, Graña, B, Salud, A, Yubero, A, Gómez-España, MA, Macías, I, Quintero, G, López-López, C, Fernández-Rodríguez, T, Grávalos, C, González-Flores, E, Guix, M, Paredes, BG, Reina, JJ, Mowbray, JRR, Sastre, J, Aranda, E. Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial. ESMO Open. 2024; 9(12)DOI:10.1016/j.esmoop.2024.103986. PMID:39608305. IF:8.300(Q1/2D).
01/12/2024
Ciprofloxacin for the Treatment of Infections Caused by Carbapenemase-Producing Gram-Negative Bacteria
Rubinan, P, Viñado, B, Fernández-Hidalgo, N, Larrosa, N, Sempere, A, Campany, D, Rodríguez-Pardo, D, González-López, JJ, Nuvials, X, del Barrio-Tofiño, E, Escolà-Vergé, L, Los-Arcos, I. Ciprofloxacin for the Treatment of Infections Caused by Carbapenemase-Producing Gram-Negative Bacteria. Antibiotics-Basel. 2024; 13(12)DOI:10.3390/antibiotics13121138. PMID:39766528. IF:4.600(Q1/2D).
01/12/2024
Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study
Abrisqueta-Costa, P, García-Marco, JA, Gutiérrez, A, Hernández-Rivas, JA, Andreu-Lapiedra, R, Arguello-Tomas, M, Leiva-Farré, C, López-Roda, MD, Callejo-Mellén, A, Alvarez-García, E, Loscertales, J. Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study. Cancers. 2024; 16(23)DOI:10.3390/cancers16234004. PMID:39682190. IF:4.400(Q2/3D).
01/12/2024
Decoding YouTube: An In-depth Analysis of Living Donor Kidney Transplantation Videos and Their Implications for Patient Education
Haberal, HB, Piana, A, Pecoraro, A, Marco, BB, Prudhomme, T, López-Abad, A, Rubau, MC, Donmez, MI, Breda, A, Territo, A. Decoding YouTube: An In-depth Analysis of Living Donor Kidney Transplantation Videos and Their Implications for Patient Education. European Urology Open Science. 2024; 70DOI:10.1016/j.euros.2024.10.005. PMID:39497749. IF:4.500(Q1/2D).
01/12/2024
Epidemiologic and clinical characteristics and course of acute heart failure and cardiogenic shock diagnosed in emergency departments
Espinosa, B, Llorens, P, Jacob, J, Gil, V, Alquézar, A, Ballarín, ED, López-Díez, MP, Garrido, JM, del Amo, S, Tost, J, Arias, PP, Llauger, L, Herrero-Puente, P, Gorlicki, J, Masip, J, Miró, O. Epidemiologic and clinical characteristics and course of acute heart failure and cardiogenic shock diagnosed in emergency departments. EMERGENCIAS. 2024; 36(6)DOI:10.55633/s3me/105.2024. PMID:39807548. IF:6.300(Q1/1D).
01/12/2024
No evidence of mutations associated with anticoagulant resistance in gene Vkorc1 in brown and black rats from Barcelona
Ruiz-López, MJ, Franco, S, Martínez-de la Puente, J, Ferraguti, M, Miccolis, E, Petit, R, Barahona, L, Figuerola, J, Montalvo, T. No evidence of mutations associated with anticoagulant resistance in gene Vkorc1 in brown and black rats from Barcelona. The Science of the total environment. 2024; 954DOI:10.1016/j.scitotenv.2024.176321. PMID:39341232. IF:8.000(Q1/2D).
01/12/2024
Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection.
Li R, Hensley PJ, Gupta S, Al-Ahmadie H, Babjuk M, Black PC, Brausi M, Bree KK, Fernández MI, Guo CC, Horowitz A, Lamm DL, Lerner SP, Lotan Y, Mariappan P, McConkey D, Mertens LS, Mir C, Ross JS, O'Donnell M, Palou J, Pohar K, Steinberg G, Soloway M, Spiess PE, Svatek RS, Tan WS, Taoka R, Buckley R, Kamat AM. Bladder-sparing Therapy for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection.. EUROPEAN UROLOGY. 2024; 86(6)DOI:10.1016/j.eururo.2024.08.001. PMID:39183090. IF:(Q/D).
30/11/2024
Amyloid-lowering treatment in Alzheimer's disease
Jessen, F, Frölich, L, Hort, J, Winblad, B, Fortea, J. Amyloid-lowering treatment in Alzheimer's disease. LANCET. 2024; 404(10468)DOI:10.1016/S0140-6736(24)02510-8. PMID:39551061. IF:88.500(Q1/1D).
30/11/2024
Evaluating the feasibility of "Friends in Nature," a complex nature-based social intervention to address loneliness and quality of life in six cities worldwide
Vert, C, Litt, JS, Gascon, M, Roqué, M, Masó-Aguado, M, Opacin, N, Garcia, G, Jansson, A, Cattaneo, L, Bártova, A, Briones-Buixassa, L, Carbó, A, Rautiainen, LJ, Hidalgo, L, Sachs, A, Domenech, S, Blancafort-Alias, S, Holmerová, I, Pitkälä, KH, Coll-Planas, L. Evaluating the feasibility of "Friends in Nature," a complex nature-based social intervention to address loneliness and quality of life in six cities worldwide. Pilot And Feasibility Studies. 2024; 10(1)DOI:10.1186/s40814-024-01575-4. PMID:39616375. IF:(Q/D).
28/11/2024
The infection post flexible UreteroreNoscopy (I-FUN) predictive model based on machine learning: a new clinical tool to assess the risk of sepsis post retrograde intrarenal surgery for kidney stone disease (vol 42, 612, 2024)
Castellani, D, De Stefano, V, Brocca, C, Mazzon, G, Celia, A, Bosio, A, Gozzo, C, Alessandria, E, Cormio, L, Ratnayake, R, Fugini, AV, Morena, T, Tanidir, Y, Sener, TE, Choong, S, Ferretti, S, Pescuma, A, Micali, S, Pavan, N, Simonato, A, Miano, R, Orecchia, L, Pirola, GM, Naselli, A, Emiliani, E, Hernandez-Penalver, P, Di Dio, M, Bisegna, C, Campobasso, D, Serafin, E, Antonelli, A, Rubilotta, E, Ragoori, D, Balloni, E, Paolanti, M, Gauhar, V, Galosi, AB. The infection post flexible UreteroreNoscopy (I-FUN) predictive model based on machine learning: a new clinical tool to assess the risk of sepsis post retrograde intrarenal surgery for kidney stone disease (vol 42, 612, 2024). WORLD JOURNAL OF UROLOGY. 2024; 42(1)DOI:10.1007/s00345-024-05390-7. PMID:39607577. IF:2.900(Q2/3D).
27/11/2024
Defining a good death: Perspectives of patients, relatives, and health care professionals in the Catalan context-A qualitative study
Serra-Sutton, V, Fernández-Giner, L, Espallargues, M, García-Altès, A. Defining a good death: Perspectives of patients, relatives, and health care professionals in the Catalan context-A qualitative study. PLoS One. 2024; 19(11)DOI:10.1371/journal.pone.0312426. PMID:39602454. IF:2.600(Q2/4D).
25/11/2024
Impact of Measured and Predicted Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement
Guthoff, H, Abdel-Wahab, M, Kim, WK, Witberg, G, Wienemann, H, Thurow, M, Shamekhi, J, Eckel, C, von der Heide, I, Veulemans, V, Landt, M, Barbanti, M, Finkelstein, A, Schewel, J, Van Mieghem, N, Adrichem, R, Toggweiler, S, Rheude, T, Nombela-Franco, L, Amat-Santos, IJ, Ruile, P, Estevez-Loureiro, R, Bunc, M, Branca, L, De Backer, O, Tarantini, G, Mylotte, D, Arzamendi, D, Pauly, M, Bleiziffer, S, Renker, M, Al-Kassou, B, Mollmann, H, Ludwig, S, Zeus, T, Tamburino, C, Schmidt, T, Rück, A, von Stein, P, Thiele, H, Abdelhafez, A, Adam, M, Baldus, S, Rudolph, T, Mauri, V. Impact of Measured and Predicted Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement. JACC-Cardiovascular Interventions. 2024; 17(22)DOI:10.1016/j.jcin.2024.08.041. PMID:39603776. IF:11.400(Q1/1D).